Agilent Technologies, Inc. - Diagnostics and Genomics SSEL XT CRE V2, 96 rxn
The Agilent SureSelect XT CRE V2, 96 rxn (part number 5190-9492) is a targeted enrichment solution designed for comprehensive analysis of clinically relevant exons (CRE) in human genomic DNA. This kit enables the preparation of up to 96 samples for next-generation sequencing (NGS) workflows, providing high specificity and uniformity in target capture. The SureSelect XT CRE V2 kit is optimized for use with Illumina sequencing platforms and supports efficient library preparation, hybridization, and capture of exonic regions associated with a wide range of genetic disorders. It is intended for research use only.